Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 87 for “"Mucoadhesion"”.

  1. Investigating the Fundamental Molecular Interactions Responsible for Polymer Mucoadhesion

    … that would otherwise not be possible. Mucoadhesion is one such example, where polymer materials are designed to enable binding with mucin proteins present in mucosa. This binding has the potential to facilitate transmucosal drug delivery with high retention times, reducing the frequency …

    toronto-retro Repository record for Investigating the Fundamental Molecular Interactions Responsible for Polymer Mucoadhesion (opens in a new tab)

  2. Role of Polymer Physicochemical Properties on in vitro Mucoadhesion

    … was likely an important factor affecting the mucoadhesion phenomenon. Different ratios of ethyl cellulose (EC) was mixed with HPMC grade K15M to form combination compacts for the purpose of modifying the surface property. The mucoadhesive mechanism of both different grades of HPMC compacts and …

    u-pacific Repository record for Role of Polymer Physicochemical Properties on in vitro Mucoadhesion (opens in a new tab)

  3. In vitro study of transbuccal drug delivery systems: Mucoadhesion of a novel bioadhesive and permeation of zalcitabine

    … constituent in bioadhesive would increase the mucoadhesion. Introducing the cationic monomer DMEMA to poly(AA-PEGMM) increased the Lewis acid-base interaction between the polymer and the buccal mucosa, which led to a thermodynamic favorable mucoadhesion process. The polymer containing 1% DMEMA …

    u-pacific Repository record for In vitro study of transbuccal drug delivery systems: Mucoadhesion of a novel bioadhesive and permeation of zalcitabine (opens in a new tab)

  4. Transbuccal drug delivery: In vitro characterization of transport pathway of buspirone and bioadhesive drug delivery system

    … aspects of buccal drug delivery, transport and mucoadhesion. Buspirone was chosen as a model drug for the in vitro buccal transport studies, polyvinyl alcohol and sodium alginate polymer blends were prepared to investigate the mucoadhesive properties through a Lewis acid-base approach and …

    u-pacific Repository record for Transbuccal drug delivery: In vitro characterization of transport pathway of buspirone and bioadhesive drug delivery system (opens in a new tab)

  5. Design and Evaluation of HIV Microbicides Loaded mucoadhesive Nanoformulation

    … cell line and Lactobacillus over 48 h. The mucoadhesion is about 12%. The CS NPs are mucoadhesive and safe as a microbicide carrier, the drawback of the CS NPs is the low EE%. In Chapter 4, the hypothesis that TFV loaded thiolated chitosan (TCS) NPs exhibit superior biophysical properties …

    umkc Repository record for Design and Evaluation of HIV Microbicides Loaded mucoadhesive Nanoformulation (opens in a new tab)

  6. Evaluation of Novel Strategies for the Inclusion of Sodium Chloride in Liquid Foods

    … concentration effects were also investigated. Mucoadhesion did not enhance salt taste. Above c*, there was a significant depression of sensory intensity, enhanced in polymers with hyperentanglements in solution. The depressive concentration effect may mask the effects of mucoadhesion. Future …

    guelph Repository record for Evaluation of Novel Strategies for the Inclusion of Sodium Chloride in Liquid Foods (opens in a new tab)

  7. Nanoencapsulation and buccal delivery system to augment bioavailability of insulin

    … the materials used in the bioadhesive layer, the mucoadhesion force of 1.12 ± 0.16 N was achieved and mucoadhesion time can be extended to more than 8 hours. Tablets with the optimized bioadhesive layer exhibited high release rate, which can release more than 90% of the insulin in 2 hours. …

    ubc Repository record for Nanoencapsulation and buccal delivery system to augment bioavailability of insulin (opens in a new tab) Download PDF for Nanoencapsulation and buccal delivery system to augment bioavailability of insulin (opens in a new tab)

  8. Development of novel formulations for mucosal delivery of protein based drugs

    … 2% mucin concentration was found optimum for mucoadhesion studies of the chitosan based xerogels. EI (glutathione; GSH and aprotinin; APR) effect on mucoadhesion was concentration dependent and inhibitor specific. In vitro BSA release profiles from annealed xerogels were similar and …

    greenwich Download PDF for Development of novel formulations for mucosal delivery of protein based drugs (opens in a new tab)

  9. Elucidating bioadhesive processes in nasal drug delivery systems

    … viscosity. Thixotropy, a vital property in mucoadhesion, was also assessed. The greatest thixotropy was found with polymers of increasing molecular weight whereas low molecular weight polymers exhibited little or no thixotropy. As expected, high molecular weight polymers produced strongly …

    strathclyde Repository record for Elucidating bioadhesive processes in nasal drug delivery systems (opens in a new tab)

  10. Development of a nasal drug delivery system using Capsella bursa-pastoris seed mucilage

    … All extracts were further examined for their mucoadhesion characteristics using Atomic Force (AFM) spectroscopy. An AFM study of the mucoadhesion of the mucilage to mucin coated mica sheets showed that the mucoadhesion power of extracted mucilage to mucin was higher than that of standard …

    strathclyde Repository record for Development of a nasal drug delivery system using Capsella bursa-pastoris seed mucilage (opens in a new tab)

  11. Formulation of novel buccal mucosal drug delivery systems for nicotine replacement therapy (NRT)

    … using texture analyser (TA) (mechanical and mucoadhesion properties), scanning electron microscopy (SEM) (surface and internal morphology), X-ray diffractometry (XRD) (physical form), attenuated total reflectance – Fourier transform infrared (ATR-FTIR) spectroscopy (physical interactions), …

    greenwich Download PDF for Formulation of novel buccal mucosal drug delivery systems for nicotine replacement therapy (NRT) (opens in a new tab)

  12. Mucoadhesive films for the buccal delivery of insulin

    … the matrix forming polymer, films with excellent mucoadhesion were developed. Here is described a high mucoadhesion for ERL that was even further increased by the addition of the water soluble PCNP. This occurred by the water movement into the ERL matrix that the solubilizing particles generate. …

    texas Repository record for Mucoadhesive films for the buccal delivery of insulin (opens in a new tab)

  13. A Long-acting Ocular Lubricant Eye Drop based on Dextran Hydrogel Nanoparticles

    … The nanoparticles are also modified to impart mucoadhesion and are thereby expected to be retained on the ocular surface for approximately 24 hours. By continuously releasing lubricant during this time, DH-NPs are anticipated to provide long-lasting and more effective DED symptom relief than …

    waterloo Repository record for A Long-acting Ocular Lubricant Eye Drop based on Dextran Hydrogel Nanoparticles (opens in a new tab)

  14. Development and characterisation of medicated wound dressings for chronic wound healing

    … films and wafers were analysed for swelling, mucoadhesion (in presence of normal and viscous simulated wound fluid), in vitro drug dissolution and anti-bacterial activity and compared against marketed medicated wound dressings. Addition of drug (STP and DLF) resulted in fair transparency of …

    greenwich Download PDF for Development and characterisation of medicated wound dressings for chronic wound healing (opens in a new tab)

  15. Development of a lower intestine targeting mucoadhesive platform of oral drug delivery

    … site. Also we developed our own in vitro mucoadhesion testing ramp as an evaluation tool. Finally, nano- and micro-structured particles were manufactured as two different oral vaccine delivery systems (Solid Lipid Nanoparticles, SLNs; and Protein Coated Microcrystals, PCMC). After the …

    texas Repository record for Development of a lower intestine targeting mucoadhesive platform of oral drug delivery (opens in a new tab)

  16. PEGylated Nanostructured Lipid Carries for Amphotericin B Ocular Delivery

    … To accomplish the aim, strategies such as mucoadhesion and/or viscosity enhancement were investigated. In this regard, PEG-NLC-AmB entrapped in ion triggered hydrogels using gellan gum (mucoadhesive) and chitosan (mucoadhesive and permeation enhancer) coated PEG-NLC-AmB were formulated and …

    mississippi Repository record for PEGylated Nanostructured Lipid Carries for Amphotericin B Ocular Delivery (opens in a new tab)

  17. Improving Decorporation Efficacy of DTPA and HOPO Using Chitosan/TPP Nanoparticles: Preparation, Characterization and Release Testing

    … decorporation agents by taking advantage of the mucoadhesion property of chitosan. The resultant CS-DTPA/TPP and CS-HOPO/TPP nanoparticles were characterized by transmission electron microscopy, Fourier transform infrared spectroscopy and dynamic light scattering, which can provide information …

    carleton Repository record for Improving Decorporation Efficacy of DTPA and HOPO Using Chitosan/TPP Nanoparticles: Preparation, Characterization and Release Testing (opens in a new tab)

  18. Analysis of poly(ethylene glycol) tethered poly(acrylic acid) networks for mucoadhesive applications

    … molecular weight PEG was incorporated to improve mucoadhesion through interpenetration and as a result improve residence time of the carrier and absorption at the drug delivery site. The dynamic swelling parameters were determined in buffer solutions containing NaCl at different pH. The …

    texas Repository record for Analysis of poly(ethylene glycol) tethered poly(acrylic acid) networks for mucoadhesive applications (opens in a new tab) Restricted access

  19. A Novel IN SITU Gel for Sustained Drug Delivery and Targeting

    … and mucin type III as the substrate for mucoadhesion. Combination of chitosan and GMO, showed a 3-7 fold increase in the mucoadhesion. In conclusion, the novel chitosan-GMO delivery system can be used both for oral and parenteral drug delivery to sustain the release of both hydrophilic …

    creighton Repository record for A Novel IN SITU Gel for Sustained Drug Delivery and Targeting (opens in a new tab) Embargoed until 2100-01-01

  20. Engineering zwitterionic and boronic acid-based nanomaterials to overcome mucosal barriers

    … glycans of mucins, facilitating selective mucoadhesion. We hypothesized that combining these opposing chemical motifs could yield materials capable of navigating the mucus barrier more effectively by balancing penetration and retention. To investigate this hypothesis, a series of model …

    colostate Repository record for Engineering zwitterionic and boronic acid-based nanomaterials to overcome mucosal barriers (opens in a new tab) Embargoed until 2027-01-07

Page 1 of 5